Clinical Trial Update: Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream [Phase 3]

View source ↗

Summary

Phase 3 bioequivalence study comparing Sol-Gel Technologies' 5-FU cream with Efudex 5-FU cream for actinic keratosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Efudex (fluorouracil)
• Sol-Gel Technologies' 5-FU cream (5-fluorouracil)

Snippet

Sponsor: Sol-Gel Technologies, Ltd. | Conditions: Actinic Keratosis (AK) | Phase 3 | Status: COMPLETED